ATNX - Athenex Inc. (ATNX) CEO Johnson Lau on Q3 2021 Results - Earnings Call Transcript

Athenex, Inc. (ATNX) Q3 2021 Earnings Conference Call November 5, 2021 08:00 ET Company Participants Caileigh Dougherty - Investor Relations Johnson Lau - Chief Executive Officer Jeff Yordon - Chief Operating Officer Rudolf Kwan - Chief Medical Officer Dan Lang - President, Athenex Cell Therapy Steve Adams - Chief Accounting Officer Kurt Gunter - Chief Medical Officer, Cell Therapy and Head, Regulatory Affairs Conference Call Participants Jonathan Miller - Evercore ISI Kennen MacKay - RBC Capital Markets Yale Jen - Laidlaw & Company Matt Kaplan - Ladenburg Thalmann Gil Blum - Needham & Company Presentation Operator Good day, ladies and gentlemen, and welcome to the Third Quarter 2021 Athenex Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to hand the conference over to Caileigh Dougherty, Director of Investor Relations. You may begin. Caileigh Dougherty Good morning and thank you

For further details see:

Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2021 Results - Earnings Call Transcript